Coherus Biosciences | Cassa E Equivalenti

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Cassa E Equivalenti Cambiamento Data
AbbVie USD 5.63B 838M 2025-09
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Akebia Therapeutics USD 166.44M 29.14M 2025-09
ALKERMES USD 616.45M 95.25M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.73B 40M 2025-09
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 103.35M 113.54M 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
Fujifilm JPY 160.88B 906M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Myriad Genetics USD 145.4M 71M 2025-09
Pacira USD 147.59M 152.89M 2025-09
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09
Xencor USD 28.29M 16.15M 2025-09
Zoetis USD 2.08B 649M 2025-09


Coherus Biosciences Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.